Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
EFTRW EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM)
0.180-0.017-8.63%
Close
02/08 16:00 ET
High
0.180
Open
0.150
Turnover
3.49K
Low
0.124
Pre Close
0.197
Volume
23.11K
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
EFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW) Short Interest Update
eFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW – Get Rating) saw a large increase in short interest during the month of January. As of January 15th, there was short interest totalling 21,500 shares, an i
EFFECTOR Therapeutics (NASDAQ:EFTRW) Trading Down 15.7%
eFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW – Get Rating) traded down 15.7% during mid-day trading on Thursday . The stock traded as low as $0.10 and last traded at $0.16. 3,151 shares were traded dur
Short Interest in EFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW) Decreases By 23.9%
eFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW – Get Rating) was the recipient of a significant decline in short interest in December. As of December 15th, there was short interest totalling 26,800 shares
EFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW) Sees Significant Decline in Short Interest
eFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW – Get Rating) was the recipient of a significant decrease in short interest in December. As of December 15th, there was short interest totalling 26,800 share
No More
Company Overview
More
eFFECTOR Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of a new class oncology drugs known as selective translation regulator inhibitors (STRIs). Its STRI product candidates target the eIF4F complex and its activating kinase, mitogen-activated protein kinase 1/2 (MNK 1/2). The company was founded by Kevan Shokat, Davide Ruggero, and Siegfried Reich on May 1, 2012 and is headquartered in San Diego, CA.
CEO： Dr. Stephen T. Worland,PhD
Market： NASDAQ
Listing Date： 01/08/2021
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet